Nektar Therapeutics’ (NKTR) CEO Howard Robin on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Howard W. Robin Thank you, Jennifer, and thanks to everyone for joining us this afternoon for our first quarter 2014 conference call. I would like to first focus on our late stage drug candidates Naloxegol, … more

View todays social media effects on NKTR

View the latest stocks trending across Twitter. Click to view dashboard

See who Nektar is hiring next, click here to view